<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xml:lang="EN" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">ACS Omega</journal-id><journal-id journal-id-type="iso-abbrev">ACS Omega</journal-id><journal-id journal-id-type="publisher-id">ao</journal-id><journal-id journal-id-type="coden">acsodf</journal-id><journal-title-group><journal-title>ACS Omega</journal-title></journal-title-group><issn pub-type="epub">2470-1343</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7469392</article-id><article-id pub-id-type="doi">10.1021/acsomega.0c02180</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Caco-2 Cell Permeability of Flavonoids and
Saponins from <italic>Gynostemma pentaphyllum</italic>: the Immortal Herb</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Ahmed</surname><given-names>Iftekhar</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Leach</surname><given-names>David N.</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Wohlmuth</surname><given-names>Hans</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>De Voss</surname><given-names>James J.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath5"><name><surname>Blanchfield</surname><given-names>Joanne T.</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><aff id="aff1"><label>&#x02020;</label>School
of Chemistry and Molecular Biosciences, <institution>The University of Queensland</institution>, St. Lucia, QLD 4072, <country>Australia</country></aff><aff id="aff2"><label>&#x02021;</label><institution>Integria
Healthcare Limited</institution>, 2728 Logan Road, Eight Mile Plains, QLD 4113, <country>Australia</country></aff><aff id="aff3"><label>&#x000a7;</label>NICM
Health Research Institute, <institution>Western Sydney
University</institution>, Westmead, Sydney, NSW 2145, <country>Australia</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Email: <email>j.blanchfield@uq.edu.au</email>.</corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>08</month><year>2020</year></pub-date><pub-date pub-type="collection"><day>01</day><month>09</month><year>2020</year></pub-date><volume>5</volume><issue>34</issue><fpage>21561</fpage><lpage>21569</lpage><history><date date-type="received"><day>11</day><month>05</month><year>2020</year></date><date date-type="accepted"><day>23</day><month>07</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 American Chemical Society</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>American Chemical Society</copyright-holder><license><license-p>This is an open access article published under an ACS AuthorChoice <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c02180_0008" id="ab-tgr1"/></p><p><italic>Gynostemma pentaphyllum</italic> (the immortal
herb) has been an important component of Chinese Traditional Medicine
for millennia. Recent clinical studies have revealed that the plant
exhibits numerous beneficial biological activities, making it of interest
to the pharmaceutical industry. An extract of the herb contains over
200 individual secondary metabolites including flavonol glycosides
and dammarane saponins. To focus attention on the compounds most likely
to be responsible for the biological activities, this study predicts
the potential oral bioavailability of nine dammarane saponins and
five flavonol glycosides from <italic>G. pentaphyllum</italic> using the Caco-2 cell monolayer permeability model. Two flavonoids, <bold>8</bold> and <bold>9</bold>, and four saponins, <bold>10</bold>, <bold>11</bold>, <bold>12</bold>, and <bold>14</bold>, exhibited high permeability
across the monolayers. The results indicated that a higher degree
of glycosylation-facilitated permeability, suggestive of active transport.
This study demonstrates the utility of the Caco-2 permeability assay
as a method of identifying possible bioavailable compounds from medicinal
herbal extracts.</p></abstract><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>ao0c02180</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>ao0c02180</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>The plant kingdom has
been sustenance, medicine, fuel, and shelter
for humankind since our first appearance on this planet. Our reliance
on plants for medicinal purposes is recorded in our most ancient civilizations.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> The use of plants or plant-derived substances
as drugs is a common feature of all civilizations, and it continues
to be a critical source of healthcare for much of the world&#x02019;s
population. The past two decades have seen the herbal medicine industry
grow from a modest to a global industry. The global herbal medicine
market was estimated to be worth US$83 billion in 2008<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> and, with a compound annual growth rate of 5.9&#x02013;7.2%,
is expected to reach US$111 billion in 2023.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> In many parts of Africa and Asia, particularly in China, over 80%
of the population relies heavily on traditional medicine for primary
healthcare.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Approximately, 20&#x02013;70%
of the population from Australia and Europe use some form of traditional
medicine in personal healthcare.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> The scientific
community has always shown significant interest in the chemistry and
bioactivity of the compounds isolated from medicinal herbs or extracts.
Hence, bioactivity-guided isolation of natural products is still one
of the major pathways for the discovery of drugs or lead molecules.
While activity-guided isolation of natural products is an excellent
strategy, a somewhat underexploited property of potentially active
compounds is the evaluation of the oral bioavailability of compounds
in a complex herbal extract. In this study, we address this issue
by investigating the potential bioavailability of the flavonoids and
saponins isolated from a Chinese medicinal herb, <italic>Gynostemma
pentaphyllum</italic> (Thunb.) Makino, using the Caco-2 cell
monolayer permeability model to provide some direction as to which
of the many compounds present in this complex herb might be responsible
for its undoubted pharmacological activity.</p><p><italic>G.
pentaphyllum</italic>, a member of the
Cucurbitaceae family, is a perennial herb, native to China, Korea,
Japan, and Vietnam, and its distribution extends to Bangladesh, Sri
Lanka, Myanmar, Thailand, Laos, Malaysia, and Indonesia.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup><italic>G. pentaphyllum</italic>, also known as &#x0201c;jiaogulan,&#x0201d; &#x0201c;the immortal herb&#x0201d;,
or &#x0201c;xiancao&#x0201d;, has been used in folk medicine for centuries
and is believed to exhibit numerous medicinal properties.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> Reports suggest that <italic>G. pentaphyllum</italic> possesses activity against asthma and inflammation,<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> obesity,<sup><xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref></sup> and hyperlipidemia<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and has shown antitumor,<sup><xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref17">17</xref></sup> antipeptic ulcer,<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> adaptogenic,<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> and cardiovascular and cerebrovascular activities.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> Most of these bioactivities exhibited by <italic>G. pentaphyllum</italic> are thought to be due to the presence
of two groups of bioactive compounds, saponins and flavonoids. Reports
suggest that approximately 165 saponins are present in <italic>G. pentaphyllum</italic>.<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref21">21</xref></sup> The major
saponins present in <italic>G. pentaphyllum</italic> belong to the dammarane class of saponins (known as gypenosides,
if isolated from <italic>G. pentaphyllum</italic>).
Dammarane saponins are characterized by a dammarane aglycone with
an acyclic side chain (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). Dammarane aglycones are tetracyclic triterpenoid sapogenins
in which C-1, C-2, C-3, C-12, and C-20 positions are either hydroxylated
or glycosylated and the C-17 position can possess a variety of modified
side chains. A variety of flavonoids have also been isolated from <italic>G. pentaphyllum</italic> with the free aglycone forms (quercetin,
kaempferol, and isorhamnetin) being reported;<sup><xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref22">22</xref></sup> however, the most prominent flavonoids present in <italic>G. pentaphyllum</italic> are found as quercetin and kaempferol
glycosides (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>).<sup><xref ref-type="bibr" rid="ref22">22</xref></sup></p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Structures of saponins isolated from <italic>G. pentaphyllum</italic>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c02180_0002" id="gr1" position="float"/></fig><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Structures
of flavonoids isolated from <italic>G. pentaphyllum</italic>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c02180_0003" id="gr2" position="float"/></fig><p>A large number of studies have
already established the diverse
pharmacological benefits of organic or aqueous crude extracts of <italic>G. pentaphyllum</italic> or of a saponin-rich extract preparation.
The extracts have shown significant activities against coronary spasm
and arrhythmia,<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> diabetes,<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> and the development of cancerous cells.<sup><xref ref-type="bibr" rid="ref41">41</xref>&#x02212;<xref ref-type="bibr" rid="ref43">43</xref></sup> The saponin-rich extracts also exhibited excellent activities against
platelet aggregation<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> and inhibited the
growth of <italic>Streptococcus mutans</italic>(<xref ref-type="bibr" rid="ref45">45</xref>) and <italic>Helicobacter pylori</italic>.<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> A recent study by Nguyen et al. reported
that two saponins, damulins A and B (<bold>15</bold> and <bold>16</bold>; <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>), isolated
from <italic>G. pentaphyllum</italic> are potential
activators of AMP-activated protein kinase (AMPK).<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> AMPK is responsible for the regulation of blood sugar levels
and lipid metabolism, consequently resulting in weight loss. Gauhar
et al. performed a follow-up <italic>in vivo</italic> study that reported
the antiobesity effect of <italic>G. pentaphyllum</italic> extract in obese mice.<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> The antiobesity
effect of <italic>G. pentaphullum</italic> was established
by a clinical trial in humans by Park et al.<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> The effects on body weight, fat loss, and metabolic markers of Korean
participants were investigated in a 12-week, randomized, double-blind,
placebo-controlled clinical trial, which suggested that <italic>G. pentaphullum</italic> supplementation may be effective
for treating obese individuals.</p><p>This highly potent, safe, and
effective plant extract could be
the first choice for treating or preventing many health disorders;
however, the complex chemical profile of <italic>G. pentaphyllum</italic> makes it difficult to identify the individual bioactive compounds
from a complex mixture (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>) of hundreds of natural products. This necessitates a systematic
approach that can differentiate the complex mixture and allow researchers
to confidently focus their attention on a smaller subset of compounds
to evaluate their potential bioactivities. Our strategy for this relies
on the knowledge that the traditional use of this herb is as an orally
ingested extract and thus the compounds most likely to be responsible
for the bioactivity must be orally bioavailable. To rapidly and efficiently
evaluate the relative potential oral bioavailability of a significant
number of compounds, the Caco-2 cell monolayer permeability model
is an ideal <italic>in vitro</italic> approach.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Liquid chromatography&#x02013;mass
spectrometry (LC&#x02013;MS) trace
of the crude methanol extract of <italic>G. pentaphyllum</italic> leaves (a) before hydrolysis and (b) after hydrolysis with HCl/methanol.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c02180_0004" id="gr3" position="float"/></fig><p>The Caco-2 cell monolayer permeability model has
emerged as the
leading <italic>in vitro</italic> tool for the assessment of potential
bioavailability of drugs in the human body. Established by Fogh in
1974,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> this model has been extensively
used in predicting <italic>in vivo</italic> oral absorption of natural
and synthetic products in humans.<sup><xref ref-type="bibr" rid="ref6">6</xref>&#x02212;<xref ref-type="bibr" rid="ref8">8</xref></sup> Caco-2 cells provide
an excellent physical and biochemical mimic of the human intestinal
epithelial membrane.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> When the cells are
cultured following specific protocols<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> and
they reach expected differentiation and confluency, they express all
the major transport proteins present in the human small intestine
such as active transporters including sugar transporters, e.g., SGLT1,
GLUT2, and GLUT5,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> thus allowing passive
diffusion as well as active and passive transport to be investigated.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> They also express efflux proteins such as P-glycoprotein
(P-gp), breast cancer resistance protein (BCRP), and multidrug resistance-associated
protein 2 (MRP-2).<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> This model enables
both apical to basolateral and basolateral to apical transport to
be studied, with the apical compartment mimicking the intestinal lumen
and the basal compartment mimicking the bloodstream. This model assesses
the apparent permeability coefficient (<italic>P</italic><sub>app</sub>) values of molecules, which is a measure of the rate at which a
compound can cross an area of the cell monolayer. The <italic>P</italic><sub>app</sub> of a number of passively diffused drugs was plotted
against the absorbed fraction of these drugs after oral administration
in humans and a clear correlation emerged, suggesting that this assay
can be used to predict the absorption in humans, provided that factors
such as the drug solubility and metabolism can be accounted for with
the help of other assays.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> These advantages
made this model our first choice to investigate the potential bioavailability
of compounds isolated from <italic>G. pentaphyllum</italic>.</p><p>Even though the chemistry of <italic>G. pentaphyllum</italic> has been extensively investigated, surprisingly, there is an extremely
low number of reports on the bioavailability of the flavonoids present
in the plant. Here, for the first time, we report the Caco-2 cell
monolayer permeability profiles of five flavonoids (<bold>2</bold>, <bold>3</bold>, <bold>4</bold>, <bold>5</bold>, and <bold>9</bold>; <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>) along
with some previously reported flavonoids for comparison: kaempferol
(<bold>1</bold>), quercetin (<bold>6</bold>), isoquercitrin (<bold>7</bold>), and rutin (<bold>8</bold>). The Caco-2 cell monolayer
permeability of dammarane saponins has never previously been investigated
and thus we report the relative <italic>in vitro</italic> monolayer
permeability profiles of nine damarane saponins (<bold>10</bold>&#x02013;<bold>18</bold>; <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>) from <italic>G. pentaphyllum</italic>.</p></sec><sec id="sec2"><title>Results and Discussion</title><p>The Caco-2 monolayer permeability assay was conducted following
standard protocols.<sup><xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref23">23</xref></sup> The Caco-2 cells were seeded
onto transwells and maintained for 21 days when they were fully confluent
and functional monolayers. The integrity of the Caco-2 monolayers
was assessed by measuring the transepithelial electrical resistance
(TEER) and the TEER values for the transwells fell within the acceptable
range (400&#x02013;600 &#x003a9;&#x000b7;cm<sup>2</sup>) for fully confluent
monolayers with well-established tight junctions between the cells.<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> The permeability assay was conducted by placing
100 &#x003bc;L of a 1 mg/mL solution (dissolved in Hank&#x02019;s buffered
salt solution (HBSS)&#x02013;4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES) buffer) of the compound to be assayed into the apical
chamber and 400 &#x003bc;L of HBSS&#x02013;HEPES buffer into the basolateral
chamber. Samples from the basal side were taken and replaced with
the equivalent amount of buffer every 30 min for 150 min. Propranolol
and fluorescein were used as the positive and negative control compounds
for the assays, respectively. Propranolol, a completely orally bioavailable
compound with &#x0003e;90% absorption in the human gastrointestinal tract,
exhibits a very high apparent permeability (<italic>P</italic><sub>app</sub>) value in Caco-2 cell permeability assays (<italic>P</italic><sub>app</sub> &#x0003e; 20 &#x000d7; 10<sup>&#x02013;6</sup> cm/s), whereas
fluorescein is a poorly orally bioavailable compound that exhibits
extremely low <italic>P</italic><sub>app</sub> values (<italic>P</italic><sub>app</sub> &#x0003c; 1 &#x000d7; 10<sup>&#x02013;6</sup> cm/s) across
Caco-2 cell monolayers. Hence, propranolol and fluorescein represent
the upper and lower bounds for the permeability assays performed on
the flavonoids and saponins reported in this paper. These control
compounds exhibited permeability values within the expected ranges,
propranolol ((56.0 &#x000b1; 8.88) &#x000d7; 10<sup>&#x02013;6</sup> cm/s)
and fluorescein ((0.1 &#x000b1; 0.002) &#x000d7; 10<sup>&#x02013;6</sup> cm/s),<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> providing further evidence of good monolayer
integrity (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).
To evaluate the physical integrity of the monolayers after exposure
to the compounds for 150 min, the permeability of fluorescein across
the washed monolayers was determined after the assay was complete
(postrun fluorescein assay). The postrun fluorescein control assay
also gave consistently low <italic>P</italic><sub>app</sub> values
(<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>) for cells
exposed to the compounds, indicating that none of the monolayers had
been damaged during the assay and that the compounds were not toxic
to the cells.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Apparent Permeability Coefficient
(<italic>P</italic><sub>app</sub>) Values of Flavonoids from <italic>G. pentaphyllum</italic> with Postrun Fluorescein Assay Values</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="char" char="."/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th style="border:none;" align="center" char=".">permeability assay</th><th style="border:none;" align="center">postrun fluorescein assay</th></tr><tr><th style="border:none;" align="center">compounds</th><th style="border:none;" align="center" char="."><italic>P</italic><sub>app</sub> (cm/s)&#x000a0;(&#x000b1;SD)&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02013;6</sup>&#x000a0;cm/s&#x000a0;(0&#x02013;150&#x000a0;min)<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref></th><th style="border:none;" align="center">*<italic>P</italic><sub>app</sub> (cm/s)&#x000a0;(&#x000b1;SD)&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02013;6</sup>&#x000a0;cm/s&#x000a0;(0&#x02013;60&#x000a0;min)<xref rid="t1fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t1fn2" ref-type="table-fn">b</xref></th></tr></thead><tbody><tr><td style="border:none;" align="left">propranolol</td><td style="border:none;" align="char" char=".">56.0&#x000a0;(&#x000b1;8.88)</td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">fluorescein</td><td style="border:none;" align="char" char=".">0.1&#x000a0;(&#x000b1;0.002)</td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left"><bold>1</bold></td><td style="border:none;" align="char" char=".">1.17&#x000a0;(&#x000b1;0.13)</td><td style="border:none;" align="left">0.38&#x000a0;(&#x000b1;0.045)</td></tr><tr><td style="border:none;" align="left"><bold>2</bold></td><td style="border:none;" align="char" char=".">1.83&#x000a0;(&#x000b1;0.34)</td><td style="border:none;" align="left">0.48&#x000a0;(&#x000b1;0.098)</td></tr><tr><td style="border:none;" align="left"><bold>3</bold></td><td style="border:none;" align="char" char=".">2.09&#x000a0;(&#x000b1;0.28)</td><td style="border:none;" align="left">0.24&#x000a0;(&#x000b1;0.059)</td></tr><tr><td style="border:none;" align="left">mixture of <bold>4</bold> and <bold>5</bold></td><td style="border:none;" align="char" char=".">6.60&#x000a0;(&#x000b1;0.75)</td><td style="border:none;" align="left">0.23&#x000a0;(&#x000b1;0.058)</td></tr><tr><td style="border:none;" align="left"><bold>6</bold></td><td style="border:none;" align="char" char=".">1.70&#x000a0;(&#x000b1;0.11)</td><td style="border:none;" align="left">0.23&#x000a0;(&#x000b1;0.06)</td></tr><tr><td style="border:none;" align="left"><bold>7</bold></td><td style="border:none;" align="char" char=".">2.05&#x000a0;(&#x000b1;0.22)</td><td style="border:none;" align="left">0.24&#x000a0;(&#x000b1;0.059)</td></tr><tr><td style="border:none;" align="left"><bold>8</bold></td><td style="border:none;" align="char" char=".">24.5&#x000a0;(&#x000b1;1.21)</td><td style="border:none;" align="left">0.48&#x000a0;(&#x000b1;0.098)</td></tr><tr><td style="border:none;" align="left"><bold>9</bold></td><td style="border:none;" align="char" char=".">36.6&#x000a0;(&#x000b1;3.2)</td><td style="border:none;" align="left">0.38&#x000a0;(&#x000b1;0.041)</td></tr></tbody></table><table-wrap-foot><fn id="t1fn1"><label>a</label><p>Average values were taken from two
different experiments.</p></fn><fn id="t1fn2"><label>b</label><p>Number
of replicates, <italic>n</italic> = 3&#x02013;4.</p></fn></table-wrap-foot></table-wrap><p>The flavonoids selected for the
permeability assay showed apparent
permeability coefficient values in the range of 1.17 (&#x000b1;0.128)
&#x000d7; 10<sup>&#x02013;6</sup> to 36.6 (&#x000b1;3.2) &#x000d7; 10<sup>&#x02013;6</sup> cm/s (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref> and <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>). A comparison of
the <italic>P</italic><sub>app</sub> values of propranolol and fluorescein
showed that the majority of the flavonoids exhibited moderate to high
monolayer permeability.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Caco-2 monolayer permeability assay on standards
and flavonoids.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c02180_0005" id="gr4" position="float"/></fig><p>Three quercetin glycosides with
varying degrees of glycosylation
were examined in this assay along with their aglycone, quercetin (<bold>6</bold>). They showed <italic>P</italic><sub>app</sub> values in
the range of 1.70 (&#x000b1;0.11) &#x000d7; 10<sup>&#x02013;6</sup> to 36.6
(&#x000b1;3.2) &#x000d7; 10<sup>&#x02013;6</sup> cm/s. All of the quercetin
glycosides showed higher <italic>P</italic><sub>app</sub> values than
that of quercetin (1.70 (&#x000b1;0.11) &#x000d7; 10<sup>&#x02013;6</sup> cm/s). Compound <bold>7</bold>, a glycoside with one sugar unit
exhibiting moderate permeability (2.05 (&#x000b1;0.22) &#x000d7; 10<sup>&#x02013;6</sup> cm/s) while compound <bold>8</bold> with two sugars
and compound <bold>9</bold> with three sugars exhibited <italic>P</italic><sub>app</sub> values of 24.5 (&#x000b1;1.21) &#x000d7; 10<sup>&#x02013;6</sup> and 36.6 (&#x000b1;3.2) &#x000d7; 10<sup>&#x02013;6</sup> cm/s, respectively.
These values corresponded to a 12-fold and 18-fold increase in permeability
compared to that of <bold>7</bold>. These results indicated that the
permeability of the quercetin glycosides increased significantly as
the degree of glycosylation increased, suggesting that glycosylation
facilitates the permeability across Caco-2 monolayers. A similar trend
was observed in the case of kaempferol glycosides. The <italic>P</italic><sub>app</sub> value for kaempferol (<bold>1</bold>) was 1.17 (&#x000b1;0.13)
&#x000d7; 10<sup>&#x02013;6</sup> cm/s, whereas compounds <bold>2</bold> and <bold>3</bold>, both having two sugar units, exhibited slightly
higher <italic>P</italic><sub>app</sub> values of 1.83 (&#x000b1;0.34)
&#x000d7; 10<sup>&#x02013;6</sup> and 2.09 (&#x000b1;0.28) &#x000d7; 10<sup>&#x02013;6</sup> cm/s, respectively. The mixture of two isorhamnetin
glycosides (<bold>4</bold> and <bold>5</bold>) also showed moderate
permeability across Caco-2 monolayers with a <italic>P</italic><sub>app</sub> value of 6.60 (&#x000b1;0.75) &#x000d7; 10<sup>&#x02013;6</sup> cm/s, indicating potential human oral bioavailability.</p><p>The <italic>P</italic><sub>app</sub> value of quercetin was higher
than that of kaempferol. The only difference between these two compounds
is the presence of a hydroxyl group at position C-3&#x02032; (<italic>R</italic><sub>2</sub>, <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>) in quercetin. This hydroxyl group is replaced by
a methoxy group in isorhamnetin derivatives. When the <italic>P</italic><sub>app</sub> values for all of the flavonol glycosides with two
sugars were compared, it was found that quercetin glycoside <bold>8</bold> showed higher monolayer permeability than the isorhamnetin
(<bold>4</bold> and <bold>5)</bold> and kaempferol glycosides (<bold>2</bold> and <bold>3</bold>). The lowest <italic>P</italic><sub>app</sub> values among these glycosides with two sugars were attributed to
the kaempferol glycosides <bold>2</bold> and <bold>3</bold>, suggesting
that the hydroxyl functionality at position 3&#x02032; may affect intestinal
permeability, possibly by facilitating transporter recognition and
binding.</p><p>A recent study correlated Caco-2 cell monolayer permeability
with
the likely oral bioavailability in humans. They characterized <italic>P</italic><sub>app</sub> values of &#x0003c;(1&#x02013;2) &#x000d7; 10<sup>&#x02013;6</sup> cm/s as low permeability corresponding to 0&#x02013;20%
human fraction absorbed (Fa), <italic>P</italic><sub>app</sub> values
of 2&#x02013;10 &#x000d7; 10<sup>&#x02013;6</sup> cm/s as moderate permeability
corresponding to 20&#x02013;80% Fa and <italic>P</italic><sub>app</sub> &#x0003e; 10 &#x000d7; 10<sup>&#x02013;6</sup> cm/s as high permeability
indicating
80&#x02013;100% Fa.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> With these values
as a guide, compounds <bold>2</bold>, <bold>3</bold>, <bold>4</bold>, <bold>5</bold>, and <bold>7</bold> with the aglycones kaempferol
and quercetin can be said to show low to moderate membrane permeability
across Caco-2 monolayers, whereas compounds <bold>8</bold> and <bold>9</bold> exhibited high Caco-2 cell permeability, making them strong
candidates for human oral bioavailability. Previous studies on the
intestinal membrane permeability of quercetin and kaempferol confirmed
that both aglycones cross Caco-2 monolayers via passive diffusion.<sup><xref ref-type="bibr" rid="ref26">26</xref>,<xref ref-type="bibr" rid="ref27">27</xref></sup> It has also been reported that glycosylation generally leads to
a decrease in Caco-2 monolayer permeability unless significant active
transport occurs.<sup><xref ref-type="bibr" rid="ref28">28</xref>&#x02212;<xref ref-type="bibr" rid="ref30">30</xref></sup> Caco-2 cells are known to express active transporters,
including sugar transporters, such as SGLT1, GLUT2, and GLUT5.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> A study by Liu et al. also reported that a sugar
transporter, SGLT1, is responsible for the transport of glycosides
in Caco-2 cells.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> Analyzing our permeability
assay data with the literature reports in mind, it can be interpreted
that the glycosylated flavonoids assessed here may be actively transported,
possibly by sugar transporters across Caco-2 monolayers.</p><p>The
nine dammarane saponins selected for an assessment in the Caco-2
monolayer permeability assay in this study displayed <italic>P</italic><sub>app</sub> values in the range of 1.33 (&#x000b1;0.073) &#x000d7; 10<sup>&#x02013;6</sup> to 35.3 (&#x000b1;5.8) &#x000d7; 10<sup>&#x02013;6</sup> cm/s (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref> and <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>). Gypenoside LVI
(<bold>11</bold>), a saponin with four sugar units, two at C-3 and
two at C-20 (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>), showed the highest <italic>P</italic><sub>app</sub> value of 35.3
(&#x000b1;5.8) &#x000d7; 10<sup>&#x02013;6</sup> cm/s, indicative of high
to complete human oral bioavailability. The lowest <italic>P</italic><sub>app</sub> value of 1.33 (&#x000b1;0.073) &#x000d7; 10<sup>&#x02013;6</sup> cm/s was attributed to damulin A (<bold>15</bold>), an E1 elimination
product of <bold>11</bold>, and a saponin with two glucose units at
C-3 (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). Gypenoside
XLVI (<bold>10</bold>), bearing three glucose units, two at C-3 and
one at C-20, exhibited a <italic>P</italic><sub>app</sub> value of
15.7 (&#x000b1;1.16) &#x000d7; 10<sup>&#x02013;6</sup> cm/s, a twofold decrease
in permeability compared to the four sugar bearing <bold>11</bold>. As seen previously for the flavonoids, a higher degree of glycosylation
also favors monolayer permeability of the saponins. Gypenosides LVI
(<bold>11</bold>) and XLVI (<bold>10</bold>) are both glycosylated
at two sites on the molecule and bear a total of four and three sugar
units, respectively, and exhibit higher <italic>P</italic><sub>app</sub> values than all saponins investigated here.</p><fig id="fig5" position="float"><label>Figure 5</label><caption><p>Caco-2 monolayer permeability
assay on standards and saponins.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c02180_0006" id="gr5" position="float"/></fig><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><title>Apparent Permeability Coefficient
(<italic>P</italic><sub>app</sub>) Values of Saponins from <italic>G. pentaphyllum</italic> with Postrun Fluorescein Assay Values</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="char" char="."/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th style="border:none;" align="center" char=".">permeability assay</th><th style="border:none;" align="center">postrun fluorescein assay</th></tr><tr><th style="border:none;" align="center">compounds</th><th style="border:none;" align="center" char=".">*<italic>P</italic><sub>app</sub> (cm/s)&#x000a0;(&#x000b1;SD)&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02013;6</sup>&#x000a0;cm/s&#x000a0;(0&#x02013;150&#x000a0;min)<xref rid="t2fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t2fn2" ref-type="table-fn">b</xref></th><th style="border:none;" align="center">*<italic>P</italic><sub>app</sub> (cm/s)&#x000a0;(&#x000b1;SD)&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02013;6</sup>&#x000a0;cm/s&#x000a0;(0&#x02013;60&#x000a0;min)<xref rid="t2fn1" ref-type="table-fn">a</xref><sup>,</sup><xref rid="t2fn2" ref-type="table-fn">b</xref></th></tr></thead><tbody><tr><td style="border:none;" align="left">propranolol</td><td style="border:none;" align="char" char=".">56.0&#x000a0;(&#x000b1;8.88)</td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left">fluorescein</td><td style="border:none;" align="char" char=".">0.1&#x000a0;(&#x000b1;0.002)</td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="border:none;" align="left"><bold>10</bold></td><td style="border:none;" align="char" char=".">15.7&#x000a0;(&#x000b1;1.16)</td><td style="border:none;" align="left">0.59&#x000a0;(&#x000b1;0.073)</td></tr><tr><td style="border:none;" align="left"><bold>11</bold></td><td style="border:none;" align="char" char=".">35.3&#x000a0;(&#x000b1;5.8)</td><td style="border:none;" align="left">0.28&#x000a0;(&#x000b1;0.047)</td></tr><tr><td style="border:none;" align="left"><bold>12</bold></td><td style="border:none;" align="char" char=".">10.7&#x000a0;(&#x000b1;2.09)</td><td style="border:none;" align="left">0.52&#x000a0;(&#x000b1;0.069)</td></tr><tr><td style="border:none;" align="left"><bold>13</bold></td><td style="border:none;" align="char" char=".">1.39&#x000a0;(&#x000b1;0.088)</td><td style="border:none;" align="left">0.59&#x000a0;(&#x000b1;0.073)</td></tr><tr><td style="border:none;" align="left"><bold>14</bold></td><td style="border:none;" align="char" char=".">13.6&#x000a0;(&#x000b1;1.61)</td><td style="border:none;" align="left">0.28&#x000a0;(&#x000b1;0.046)</td></tr><tr><td style="border:none;" align="left"><bold>15</bold></td><td style="border:none;" align="char" char=".">1.33&#x000a0;(&#x000b1;0.073)</td><td style="border:none;" align="left">0.52&#x000a0;(&#x000b1;0.013)</td></tr><tr><td style="border:none;" align="left"><bold>16</bold></td><td style="border:none;" align="char" char=".">3.56&#x000a0;(&#x000b1;0.530)</td><td style="border:none;" align="left">0.21&#x000a0;(&#x000b1;0.037)</td></tr><tr><td style="border:none;" align="left"><bold>17</bold></td><td style="border:none;" align="char" char=".">5.8&#x000a0;(&#x000b1;0.770)</td><td style="border:none;" align="left">0.52&#x000a0;(&#x000b1;0.012)</td></tr><tr><td style="border:none;" align="left"><bold>18</bold></td><td style="border:none;" align="char" char=".">6.2&#x000a0;(&#x000b1;0.248)</td><td style="border:none;" align="left">0.51&#x000a0;(&#x000b1;0.075)</td></tr></tbody></table><table-wrap-foot><fn id="t2fn1"><label>a</label><p>Average values were taken from two
different experiments.</p></fn><fn id="t2fn2"><label>b</label><p>Number
of replicates, <italic>n</italic> = 3&#x02013;4.</p></fn></table-wrap-foot></table-wrap><p>Gypenoside L (<bold>12</bold>),
with the C-3 disaccharide, showed
high permeability with a <italic>P</italic><sub>app</sub> value of
10.7 (&#x000b1;2.09) &#x000d7; 10<sup>&#x02013;6</sup> cm/s. Interestingly,
gypenoside LI (<bold>13</bold>), the 20<italic>R</italic>-epimer of <bold>12</bold>, exhibited a 10-fold decrease in permeability (1.39 (&#x000b1;0.088)
&#x000d7; 10<sup>&#x02013;6</sup> cm/s). This may suggest that the stereochemistry
at C-20 (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>)
can be a significant factor for determining the monolayer permeability
of the saponins. Yixinoside B (<bold>14</bold>) exhibits the same
C-20 stereochemistry as <bold>12</bold> and bears two glucose units
attached through the hydroxy group at C-3 but is hydroxylated at position
C-1 rather than at C-2 as seen in <bold>12</bold> and <bold>13</bold> (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). This
structural isomer of <bold>12</bold> exhibited a slightly higher <italic>P</italic><sub>app</sub> value (13.6 (&#x000b1;1.61) &#x000d7; 10<sup>&#x02013;6</sup> cm/s) than <bold>12</bold>, suggesting that a saponin possessing
a hydroxyl group at C-1 and <italic>S</italic>-configuration at C-20
is more permeable across Caco-2 monolayers than its structural or
configurational isomers.</p><p>The E1 products of gypenosides LVI
and XLVI, the damulins A (<bold>15</bold>) and B (<bold>16</bold>)
(C-2-OH) and the C-3-OH isomers,
damulins E (<bold>17</bold>) and F (<bold>18</bold>), exhibited low
to moderate monolayer permeability with <italic>P</italic><sub>app</sub> values ranging from 1.33 (&#x000b1;0.073) to 6.2 (&#x000b1;0.248) &#x000d7;
10<sup>&#x02013;6</sup> cm/s. Damulins A and B (<bold>15</bold> and <bold>16</bold>) differ only in the position of the double bond at C-20
of the side chain, with <bold>15</bold> being the &#x00394;<sup>20,22</sup> isomer and <bold>16</bold> the less stable terminal double-bond
isomer (&#x00394;<sup>20,21</sup>). Damulins E and F (<bold>17</bold> and <bold>18</bold>) share the same structural relationship (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). A comparison of
the Caco-2 cell monolayer permeability of these compounds reveals
a slight increase in apparent permeability in those compounds with
the terminal double bound <bold>16</bold> and <bold>18</bold>. The
previous comparison of the permeability of gypenoside L (<bold>12</bold>) and yixinoside B (<bold>14</bold>) suggested that hydroxylation
at C-1 favored permeability over hydroxylation at C-2 and a similar
trend was observed for the damulins. Damulins E and F (<bold>17</bold> and <bold>18</bold>), both having hydroxyl group at C-1, exhibited
higher <italic>P</italic><sub>app</sub> values than that of the C2-OH
isomers, damulins A and B (<bold>15</bold> and <bold>16</bold>). This
confirms that the monolayer permeability is facilitated by the presence
of a hydroxyl group at C-1 more than at C-2. The analysis of the <italic>P</italic><sub>app</sub> values confirmed that compounds <bold>15</bold>&#x02013;<bold>18</bold> showed low to moderate permeability across
Caco-2 monolayers, whereas the compounds <bold>10</bold>, <bold>11</bold>, <bold>12</bold>, and <bold>14</bold> exhibited high Caco-2 cell
monolayer permeability, making them strong candidates with the potential
for high oral absorption <italic>in vivo</italic>.</p><p>A literature
survey confirmed the lack of any report on the permeability
of dammarane saponins. However, reports suggest that the other class
of saponins, the steroidal saponins, can pass through Caco-2 monolayers.
These saponins are actively transported by suitable transport proteins,
such as sugar transporters, or can be effluxed across the monolayers
by efflux pumps such as P-gp and MRP-2.<sup><xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref32">32</xref>&#x02212;<xref ref-type="bibr" rid="ref36">36</xref></sup> We know that Caco-2 cells express active transporters including
sugar transporters such as SGLT1 (responsible for the transport of
glycosides),<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> GLUT2 and GLUT5.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Analysis of our permeability assay data in light
of these literature reports suggests that the glycosylated saponins
assessed here may be actively transported by sugar transporters across
Caco-2 monolayers. The low permeability of saponins <bold>13</bold> and <bold>15</bold> may be attributed to the fact that these saponins
are effluxed across Caco-2 monolayers by suitable efflux pumps such
as P-gp and MRP-2. An inhibitory transport study can be used in the
future to determine the specific transporters or efflux proteins that
are involved.</p></sec><sec id="sec3"><title>Conclusions</title><p><italic>G. pentaphyllum</italic> is an important
medicinal herb with promising and clinically important biological
activities. It also contains a plethora of structurally diverse natural
products, any or all of which may be responsible for the activities
observed for the extracts. Our study identifies the compounds most
likely to be orally available from the complex mixture that is ingested
as &#x0201c;the immortal tea&#x0201d;. The Caco-2 cell monolayer permeability
assay on the flavonoids and saponins from <italic>G. pentaphyllum</italic> resulted in the identification of strong candidates for potential
human oral bioavailability. The study indicated that kaempferol glycosides <bold>2</bold>&#x02013;<bold>5</bold> exhibited moderate to high permeability
across Caco-2 cell monolayers. A notable observation was that the <italic>P</italic><sub>app</sub> value was not significantly affected by
the presence of different sugar units as galactose-containing compounds <bold>2</bold> and <bold>4</bold> showed similar <italic>P</italic><sub>app</sub> values to the glucose-containing compounds <bold>3</bold> and <bold>5</bold>, respectively. The quercetin glycoside <bold>7</bold> also exhibited moderate permeability across Caco-2 cell
monolayers, whereas other quercetin glycosides <bold>8</bold> and <bold>9</bold> with a higher degree of glycosylation exhibited high Caco-2
cell permeability. Quercetin glycosides exhibited higher permeability
across Caco-2 monolayers than kaempferol and isorhamnetin glycosides.
It was also observed that the permeability of the glycosides was dependent
on the number of sugar units attached to the aglycone and the number
of glycosylation sites with a higher degree of glycosylation facilitating
the permeability across Caco-2 cell monolayers. <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref> provides a summary of the key structural
features that our data suggest are critical for enhanced permeability
across Caco-2 cell monolayers and therefore for potential bioavailability.</p><fig id="fig6" position="float"><label>Figure 6</label><caption><p>Summary
of the structural features of <italic>G. pentaphylum</italic> flavonoids and saponins that enhance permeability across Caco-2
cell monolayers. Key structural features highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c02180_0007" id="gr6" position="float"/></fig><p>A similar trend was observed for the highly glycosylated
dammarane
saponins, <bold>10</bold> and <bold>11</bold>, where the permeability
across Caco-2 cell monolayers was favored by a higher degree of glycosylation.
Analysis of the structure&#x02013;permeability correlations revealed
that saponins with a hydroxyl group at C-1 and <italic>S</italic>-configuration
at C-20 were more permeable across Caco-2 cell monolayers than the
structural or configurational isomers. It was also observed that the
compounds that result from the elimination of the C-20-OH group, compounds <bold>15</bold>&#x02013;<bold>18</bold>, showed low to moderate permeability
across Caco-2 cell monolayers, whereas the precursor compounds, <bold>10</bold>, <bold>11</bold>, <bold>12</bold>, and <bold>14</bold>,
exhibited high Caco-2 cell monolayer permeability, making them strong
candidates for possible complete human oral bioavailability. <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref> depicts these permeability-enhancing
structural features highlighted in red. Based on the literature reports
on the bioavailability of other classes of saponins and comparison
with our results, we propose that the flavonoids and saponins with
moderate to high permeability across Caco-2 cell monolayers are transported
via active transport, possibly by sugar transporters. This study does
not implicate the involvement of specific uptake transporters or efflux
pumps. In the future, transport studies can be utilized to determine
the specific transporters involved in the active transport of these
compounds. This was the first bioavailability study of dammarane saponins
and also of a number of flavonoids from <italic>G. pentaphyllum</italic>, and the results have definite significance in allowing future bioavailability
assays to identify potential drugs for oral administration or structures
for lead optimization.</p></sec><sec id="sec4"><title>Experimental Section</title><sec id="sec4.1"><title>General Procedures</title><p>Human colorectal adenocarcinoma
(Caco-2) cells were purchased from American Type Cell Culture Collection
(ATCC, Rockville, MD). The cells were cultured and maintained using
standard protocols.<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> Dulbecco&#x02019;s
modified Eagle&#x02019;s Medium (DMEM), Hanks&#x02019; Balanced Salts
Solution (HBSS), 4-(2-hydroxyethyl)-1-piperazineethane-sulfonic acid
(HEPES), minimum essential medium (MEM) nonessential amino acids (NEAAs),
trypsin-0.25% ethylenediaminetetraacetic acid (EDTA) solution, phosphate-buffered
saline (PBS) solution, and penicillin&#x02013;streptomycin antibiotic
solution were purchased from Gibco Laboratories (Life Technologies
Inc., Grand Island, NY). Fetal bovine serum (FBS) was bought from
Sigma Aldrich Pty Ltd (Castle Hill, NSW, Australia). Transwell plates
(24 wells, 6.5 mm polycarbonate inserts, 0.4 &#x003bc;m pore) were obtained
from Corning Costar (Cambridge, MA) and LCMS grade acetonitrile solvent
was from Fisher Scientific (Hampton, NH).</p></sec><sec id="sec4.2"><title>Cell Culture</title><p>Flask
media was prepared with DMEM supplemented
with 1% NEAA and 10% prefiltered (0.22 &#x003bc;m) FBS. Plate media
was made up of flask media and additionally supplemented with 1% penicillin
(5000 units/mL)-streptomycin (5000 &#x003bc;g/mL) antibiotic. Freezing
media was made up of flask media and additionally supplemented with
10% dimethyl sulfoxide (DMSO).</p><p>Caco-2 cells (passage 34) were
removed from the &#x02212;80 &#x000b0;C freezer, thawed in a water bath
at 37 &#x000b0;C for 1&#x02013;2 min, resuspended in flask media (5 mL),
and centrifuged (1000 rpm, 5 min). After discarding the supernatant,
the cells were resuspended in flask media (1&#x02013;2 mL). Gentle
mixing using a 5 mL serological pipette gave a homogeneous mixture.
The cells were then seeded into 75 cm<sup>2</sup> flasks (Thermo Scientific)
by transferring cell suspension (0.5&#x02013;1 mL) and flask media
(10 mL) to each flask. The flasks were stored in an incubator (37
&#x000b0;C, 5% CO<sub>2</sub>, 95% relative humidity). The media in the
flask was changed every two days until the cells reached 80&#x02013;85%
confluency at which time the cells were passaged or plated.</p><p>To passage the cells, flask media was removed and the cells were
washed with PBS (2 &#x000d7; 1&#x02013;2 mL). Trypsin&#x02013;0.25% EDTA
(3 mL) was added and the flasks were incubated for 5 min, agitated
2&#x02013;3 times to encourage cell detachment. Following successful
detachment, flask media (3 mL per 1 mL trypsin) were added and the
cells were centrifuged (1000 rpm, 5 min). The supernatant was discarded
and the cells were resuspended homogeneously in the flask media (1&#x02013;2
mL). The cells were seeded into fresh flasks and maintained as previously
described.</p><p>To seed the cells into transwell plates, the plates
were preincubated
with plate media (100 &#x003bc;L apical and 600 &#x003bc;L basal) for
at least 30 min. The protocol for passaging cells was followed until
the removal of supernatant from centrifuged cells. Cells were then
resuspended in plate media (4&#x02013;5 mL) and counted on a hemocytometer
(BlauBrand), and the cell resuspension dilution was adjusted to a
density of 1 &#x000d7; 10<sup>5</sup> cells/mL. The media were then removed
from the plates, the basal side was refreshed (600 &#x003bc;L), and
cells (passage 38) were seeded onto the apical side (100 &#x003bc;L).
Plates were cultured in an incubator (37 &#x000b0;C, 5% CO<sub>2</sub>, 95% relative humidity) for 21 days. Plate media were refreshed
every 48 h until day 8. From day 8 and later, apical plate media were
refreshed every 24 h, while the 48 h feeding pattern was maintained
for the basal side. On day 21, all plate media were refreshed and
TEER values were measured (Millicell Electrical Resistance System
(ERS-2) volt ohmmeter). Values in the acceptable range of 400&#x02013;600
&#x003a9;&#x000b7;cm<sup>2</sup> were recorded. Wells were arranged in
descending order of TEER value to minimize variation between compound
replicates.</p></sec><sec id="sec4.3"><title>Extraction, Isolation, and Characterization
of Flavonoids and
Saponins</title><p>The flavonoids selected for the assay were extracted,
isolated, and purified from a methanol extract of <italic>G.
pentaphyllum</italic> leaves (flavonoids) and the saponins
from the ethanol extract of ActivAMP powder, a commercial saponin-rich
preparation of <italic>G. pentaphyllum</italic> leaves.
The plant material was originally sourced from Fujian, China, by Huisong
Pharmaceuticals, China. Dried leaves of <italic>G. pentaphyllum</italic> were purchased from Huisong Pharmaceuticals, China (Lot No. GP112-160602).
The extract identification, specification, and certificate of analysis
were prepared by Hongbin Chen and authorized by Liuzi Huang from Huisong
Pharmaceuticals. ActivAMP powder was purchased from Gencor Pacific
Limited (Batch No. BGP30151001). The certificate of analysis was prepared
by Gencor Pacific Limited.</p><p>Dried leaves of <italic>G.
pentaphyllum</italic> (10 g) were extracted with 50% aqueous
methanol (100 mL), followed by sonication (3 &#x000d7; 10 min). After
filtration and removal of the solvent, the crude extract (1 g) was
partially purified by solid-phase extraction (Phenomenex Strata C-18E
cartridge, 55 &#x003bc;m, 70 &#x000c5;), eluted with water, followed by
10, 20, 30, and 40% aqueous methanol and 100% methanol taking three
aliquots (3 &#x000d7; 100 mL) of each solvent composition. The 30% aqueous
methanol fraction (103 mg) was dried, dissolved in 20% aqueous acetonitrile
(6 mL), filtered (0.22 &#x003bc;m Millex syringe filter), and further
purified by column chromatography using preparative reversed-phase
high-pressure liquid chromatography (RPHPLC) (gradient elution, 2&#x02013;20%
aqueous acetonitrile over 25 min, 25.0 mL/min) to give compounds <bold>1&#x02013;9</bold> that were identified by literature values from
nuclear magnetic resonance and mass spectrometry analyses.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup></p><p>ActivAMP powder form of <italic>G. pentaphyllum</italic> (10 g) was extracted with 60% aqueous
ethanol (100 mL), followed
by sonication (3 &#x000d7; 10 min). After filtration and removal of the
solvent, the crude extract (1 g) was partially purified by solid-phase
extraction (Phenomenex Strata C-18E cartridge, 55 &#x003bc;m, 70 &#x000c5;),
eluted with water, followed by 60, 70, 80, and 90% aqueous methanol
and 100% aqueous methanol taking three aliquots (3 &#x000d7; 100 mL)
of each solvent composition. The 70% aqueous methanol fraction (116.2
mg) was dried, dissolved in 50% aqueous acetonitrile (6 mL), filtered
(0.22 &#x003bc;m Millex syringe filter), and further purified by column
chromatography using semipreparative RPHPLC (40% aqueous acetonitrile
isocratic over 30 min, 2.0 mL/min) to give compounds <bold>10</bold>&#x02013;<bold>18</bold> that were identified by literature values
from nuclear magnetic resonance and mass spectrometry analyses.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup></p></sec><sec id="sec4.4"><title>Preparation of Assay Samples, Standard Solutions,
and Calibration
Curves</title><p>Compound solutions (1 mg/mL) and propranolol (0.1
mM, 0.026 mg/mL) and fluorescein (0.4 mg/mL) standards were made up
in warmed HBSS (pH 7.4) containing 25 mM HEPES and sonicated to maximize
dissolution.</p><p>To produce the calibration curves, stock solutions
of all of the compounds (1000 ppm) were made in the HBSS/HEPES buffer.
The stock solutions were serially diluted to achieve concentrations
of 500, 250, 125, 100, 50, 25, 12.5, 10, 5, 2.5, and 1 ppm. The solutions
were analyzed by LCMS, and the calibration curves were assembled using
Microsoft Excel 2016.</p></sec><sec id="sec4.5"><title>Permeability Assay</title><p>The apical and
basolateral compartments
of the wells were prepared by removing all media, washing twice with
PBS and twice with warmed HBSS/HEPES buffer, gently aspirating to
remove all possible liquid, loading fresh buffer, and incubating the
plates for 30 min. The buffer was removed and the wells gently aspirated
to remove all possible liquid. Fresh buffer was loaded into the basal
sides (600 &#x003bc;L) and the compounds and the standards were loaded
into quadruplicate apical wells (100 &#x003bc;L). Then, the plates were
placed into a shaking incubator (37 &#x000b0;C, 55 rpm). The samples
were taken from the basal side (200 &#x003bc;L) and replaced with buffer
every 30 min for 150 min. At 150 min, the apical side was also collected.
The samples were stored at &#x02212;80 &#x000b0;C for further LCMS analysis.</p></sec><sec id="sec4.6"><title>Fluorescein Postrun Control Assay</title><p>Transwells were prepared
by removing all media and washing twice with PBS buffer and twice
with prewarmed HBSS/HEPES buffer. Fluorescein (100 &#x003bc;L) was loaded
into each apical well used for compounds. The plates were placed in
the shaking incubator (37 &#x000b0;C, 55 rpm). The samples were taken
from the basal side (200 &#x003bc;L) and replaced with buffer every
20 min for 60 min. The samples were stored at &#x02212;80 &#x000b0;C for
further analysis. The fluorescein postrun control assay was not conducted
on the propranolol or fluorescein wells.</p></sec><sec id="sec4.7"><title>Sample Analysis</title><p>Fluorescein standard solutions for
calibration curves, fluorescein standard solutions for permeability
assay, and postrun samples were analyzed in 96-well plates using ultraviolet&#x02013;visible
(UV&#x02013;vis) spectrophotometry (490 nm, BioRad Microplate Reader).
The compounds and propranolol standards were analyzed on a Shimadzu
LCMS-2020 system using an analytical column (Shim-pack XR-ODSIII 2.0
mm i.d &#x000d7; 150 mm, flow rate of 0.25 mL/min, column oven at 40
&#x000b0;C). Acetonitrile with 0.1% formic acid and ultrapure water (Milli-Q)
with 0.1% formic acid were used as mobile phases. A gradient elution
system was used. The initial solvent concentration was kept at 5%
aq. acetonitrile for 5 min, then increased up to 80% aq. acetonitrile
over 2 min, and held for 8 min.</p><p>Compound peak areas were individually
integrated from MS data on selected ion monitoring (SIM) mode and
processed, and <italic>P</italic><sub>app</sub> values were calculated
by the following equation<disp-formula id="ueq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c02180_m001" position="anchor"/></disp-formula>where <italic>V</italic><sub>R</sub> is the
volume in the receiver chamber, <italic>A</italic> is the surface
area of the monolayer, <italic>C</italic><sub>0</sub> is the initial
concentration in the donor chamber (apical) at 0 min, and d<italic>C</italic>/d<italic>T</italic> is the steady-state linear rate of
change of concentration in the receiver chamber (basal) (&#x003bc;g/sec).
The rate of drug transport was calculated by linear regression analysis
using Microsoft Excel 2016 software (Microsoft Corporation, Redmond,
WA). All data were presented as mean &#x000b1; SD in cm/s &#x000d7; 10<sup>&#x02013;6</sup>.</p></sec></sec></body><back><notes id="notes-1" notes-type="si"><title>Supporting Information Available</title><p>The Supporting Information
is available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acsomega.0c02180?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsomega.0c02180</ext-link>.<list id="silist" list-type="simple"><list-item><p>Table of TEER values;
calculation of the rate of drug
transport by linear regression analysis (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02180/suppl_file/ao0c02180_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c02180_si_001.pdf"><caption><p>ao0c02180_si_001.pdf</p></caption></media></supplementary-material></sec><notes notes-type="" id="notes-2"><title>Author Contributions</title><p>The manuscript
was written through contributions of all authors. All authors have
given approval to the final version of the manuscript.</p></notes><notes notes-type="funding-statement" id="notes-3"><p>This research
is supported by an Australian Research Council Linkage (LP14) Grant
in collaboration with Integria Healthcare and Research Training Program
(RTP) scholarship to I.A.</p></notes><notes notes-type="COI-statement" id="NOTES-d7e1758-autogenerated"><p>The authors declare no
competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>Dr. I.A. acknowledges
the support of a Research Training Program
(RTP) scholarship during his Ph.D. candidature.</p></ack><glossary id="dl1"><def-list><title>Abbreviations Used</title><def-item><term><italic>P</italic><sub>app</sub></term><def><p>apparent
permeability coefficient</p></def></def-item><def-item><term>TEER</term><def><p>transepithelial electrical resistance</p></def></def-item><def-item><term>HBSS</term><def><p>Hank&#x02019;s buffered salt solution</p></def></def-item><def-item><term>HEPES</term><def><p>4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid</p></def></def-item><def-item><term>LCMS</term><def><p>liquid
chromatography mass spectrometry</p></def></def-item><def-item><term>NEAA</term><def><p>nonessential amino acids</p></def></def-item><def-item><term>DMEM</term><def><p>Dulbecco&#x02019;s modified Eagle&#x02019;s
medium</p></def></def-item><def-item><term>FBS</term><def><p>fetal
bovine serum</p></def></def-item><def-item><term>DMSO</term><def><p>dimethyl sulfoxide</p></def></def-item><def-item><term>RPHPLC</term><def><p>reversed-phase high-pressure liquid chromatography</p></def></def-item><def-item><term>rpm</term><def><p>revolutions per minute</p></def></def-item><def-item><term>ppm</term><def><p>parts per million</p></def></def-item><def-item><term>SIM</term><def><p>selected ion mode
monitoring</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Petrovska</surname><given-names>B. B.</given-names></name>
<article-title>Historical
review of medicinal plants&#x02019; usage</article-title>. <source>Pharmacogn.
Rev.</source>
<year>2012</year>, <volume>6</volume>, <fpage>1</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.4103/0973-7847.95849</pub-id>.<pub-id pub-id-type="pmid">22654398</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="report" id="cit2"><person-group person-group-type="allauthors"><name><surname>Robinson</surname><given-names>M. M.</given-names></name>; <name><surname>Zhang</surname><given-names>X.</given-names></name></person-group><source>The World Medicines Situation
2011, Traditional Medicines: Global Situation, Issues and Challenges</source>; 3rd ed., <publisher-name>World Health Organization</publisher-name>: <publisher-loc>Geneva</publisher-loc>, <year>2011</year>; pp <fpage>1</fpage>&#x02013;<lpage>4</lpage>.</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="weblink" id="cit3"><person-group person-group-type="allauthors"><name><surname>Trent</surname><given-names>N.</given-names></name></person-group><article-title>Herbal Medicine
Market 2018 Global Share, Trend, Segmentation and Forecast to 2023</article-title>. <year>2019</year>; <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.reuters.com/brandfeatures/venture-capital/article?id=66628">https://www.reuters.com/brandfeatures/venture-capital/article?id=66628</uri> (accessed September 9, 2019).</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Frenkel</surname><given-names>M. A.</given-names></name>; <name><surname>Borkan</surname><given-names>J. M.</given-names></name>
<article-title>An approach for integrating complementary&#x02013;alternative
medicine into primary care</article-title>. <source>Fam. Pract.</source>
<year>2003</year>, <volume>20</volume>, <fpage>324</fpage>&#x02013;<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1093/fampra/cmg315</pub-id>.<pub-id pub-id-type="pmid">12738703</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="book" id="cit5"><person-group person-group-type="allauthors"><name><surname>Fogh</surname><given-names>J.</given-names></name>; <name><surname>Trempe</surname><given-names>G.</given-names></name></person-group><article-title>New Human Tumor
Cell Lines</article-title>. In <source>Human Tumor Cells in Vitro</source>; <publisher-name>Springer</publisher-name>, <year>1975</year>; pp <fpage>115</fpage>&#x02013;<lpage>159</lpage>.</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Lennern&#x000e4;s</surname><given-names>H.</given-names></name>; <name><surname>Palm</surname><given-names>K.</given-names></name>; <name><surname>Fagerholm</surname><given-names>U.</given-names></name>; <name><surname>Artursson</surname><given-names>P.</given-names></name>
<article-title>Comparison
between active and passive drug transport in human intestinal epithelial
(Caco-2) cells in vitro and human jejunum in vivo</article-title>. <source>Int. J. Pharm.</source>
<year>1996</year>, <volume>127</volume>, <fpage>103</fpage>&#x02013;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/0378-5173(95)04204-0</pub-id>.</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Artursson</surname><given-names>P.</given-names></name>; <name><surname>Karlsson</surname><given-names>J.</given-names></name>
<article-title>Correlation between
oral drug absorption in humans
and apparent drug permeability coefficients in human intestinal epithelial
(Caco-2) cells</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<year>1991</year>, <volume>175</volume>, <fpage>880</fpage>&#x02013;<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1016/0006-291X(91)91647-U</pub-id>.<pub-id pub-id-type="pmid">1673839</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Peng</surname><given-names>Y.</given-names></name>; <name><surname>Yadava</surname><given-names>P.</given-names></name>; <name><surname>Heikkinen</surname><given-names>A. T.</given-names></name>; <name><surname>Parrott</surname><given-names>N.</given-names></name>; <name><surname>Railkar</surname><given-names>A. J.</given-names></name>
<article-title>Applications
of a 7-day Caco-2 cell model in drug discovery and development</article-title>. <source>Eur. J. Pharm. Sci.</source>
<year>2014</year>, <volume>56</volume>, <fpage>120</fpage>&#x02013;<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejps.2014.02.008</pub-id>.<pub-id pub-id-type="pmid">24576578</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Matthias</surname><given-names>A.</given-names></name>; <name><surname>Blanchfield</surname><given-names>J.</given-names></name>; <name><surname>Penman</surname><given-names>K.</given-names></name>; <name><surname>Toth</surname><given-names>I.</given-names></name>; <name><surname>Lang</surname><given-names>C. S.</given-names></name>; <name><surname>De Voss</surname><given-names>J.</given-names></name>; <name><surname>Lehmann</surname><given-names>R.</given-names></name>
<article-title>Permeability studies of alkylamides
and caffeic acid conjugates from Echinacea using a Caco-2 cell monolayer
model</article-title>. <source>J. Clin. Pharm. Ther.</source>
<year>2004</year>, <volume>29</volume>, <fpage>7</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2710.2003.00530.x</pub-id>.<pub-id pub-id-type="pmid">14748892</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Xiong</surname><given-names>J.</given-names></name>; <name><surname>Sun</surname><given-names>M.</given-names></name>; <name><surname>Guo</surname><given-names>J.</given-names></name>; <name><surname>Huang</surname><given-names>L.</given-names></name>; <name><surname>Wang</surname><given-names>S.</given-names></name>; <name><surname>Meng</surname><given-names>B.</given-names></name>; <name><surname>Ping</surname><given-names>Q.</given-names></name>
<article-title>Active absorption
of ginsenoside Rg1 in vitro and in vivo: the role
of sodium-dependent glucose co-transporter 1</article-title>. <source>J. Pharm. Pharmacol.</source>
<year>2009</year>, <volume>61</volume>, <fpage>381</fpage>&#x02013;<lpage>386</lpage>. <pub-id pub-id-type="doi">10.1211/jpp/61.03.0014</pub-id>.<pub-id pub-id-type="pmid">19222912</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Fang</surname><given-names>Y.</given-names></name>; <name><surname>Liang</surname><given-names>F.</given-names></name>; <name><surname>Liu</surname><given-names>K.</given-names></name>; <name><surname>Qaiser</surname><given-names>S.</given-names></name>; <name><surname>Pan</surname><given-names>S.</given-names></name>; <name><surname>Xu</surname><given-names>X.</given-names></name>
<article-title>Structure characteristics
for intestinal uptake of flavonoids in
Caco-2 cells</article-title>. <source>Food Res. Int.</source>
<year>2018</year>, <volume>105</volume>, <fpage>353</fpage>&#x02013;<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodres.2017.11.045</pub-id>.<pub-id pub-id-type="pmid">29433224</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="book" id="cit12"><person-group person-group-type="allauthors"><name><surname>Blumert</surname><given-names>M.</given-names></name>; <name><surname>Liu</surname><given-names>J.</given-names></name></person-group><source>Jiaogulan: China&#x02019;s Immortality
Herb</source>, <publisher-name>Torchlight Pub.</publisher-name>, <year>1999</year>.</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Hung</surname><given-names>T. M.</given-names></name>; <name><surname>Thu</surname><given-names>C. V.</given-names></name>; <name><surname>Cuong</surname><given-names>T. D.</given-names></name>; <name><surname>Hung</surname><given-names>N. P.</given-names></name>; <name><surname>Kwack</surname><given-names>S. J.</given-names></name>; <name><surname>Huh</surname><given-names>J.-I.</given-names></name>; <name><surname>Min</surname><given-names>B. S.</given-names></name>; <name><surname>Choi</surname><given-names>J. S.</given-names></name>; <name><surname>Lee</surname><given-names>H. K.</given-names></name>; <name><surname>Bae</surname><given-names>K.</given-names></name>
<article-title>Dammarane-type glycosides
from <italic>Gynostemma pentaphyllum</italic> and their
effects on IL-4-induced eotaxin expression in human bronchial
epithelial cells</article-title>. <source>J. Nat. Prod.</source>
<year>2010</year>, <volume>73</volume>, <fpage>192</fpage>&#x02013;<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1021/np9006712</pub-id>.<pub-id pub-id-type="pmid">20104880</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Park</surname><given-names>S. H.</given-names></name>; <name><surname>Huh</surname><given-names>T. L.</given-names></name>; <name><surname>Kim</surname><given-names>S. Y.</given-names></name>; <name><surname>Oh</surname><given-names>M. R.</given-names></name>; <name><surname>Tirupathi
Pichiah</surname><given-names>P.</given-names></name>; <name><surname>Chae</surname><given-names>S. W.</given-names></name>; <name><surname>Cha</surname><given-names>Y. S.</given-names></name>
<article-title>Antiobesity effect
of <italic>Gynostemma pentaphyllum</italic> extract
(actiponin): A randomized, double-blind, placebo-controlled trial</article-title>. <source>Obesity</source>
<year>2014</year>, <volume>22</volume>, <fpage>63</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1002/oby.20539</pub-id>.<pub-id pub-id-type="pmid">23804546</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Nguyen</surname><given-names>P. H.</given-names></name>; <name><surname>Gauhar</surname><given-names>R.</given-names></name>; <name><surname>Hwang</surname><given-names>S. L.</given-names></name>; <name><surname>Dao</surname><given-names>T. T.</given-names></name>; <name><surname>Park</surname><given-names>D. C.</given-names></name>; <name><surname>Kim</surname><given-names>J. E.</given-names></name>; <name><surname>Song</surname><given-names>H.</given-names></name>; <name><surname>Huh</surname><given-names>T. L.</given-names></name>; <name><surname>Oh</surname><given-names>W. K.</given-names></name>
<article-title>New dammarane-type
glucosides as potential activators of AMP-activated protein kinase
(AMPK) from <italic>Gynostemma pentaphyllum</italic></article-title>. <source>Bioorg. Med. Chem.</source>
<year>2011</year>, <volume>19</volume>, <fpage>6254</fpage>&#x02013;<lpage>6260</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2011.09.013</pub-id>.<pub-id pub-id-type="pmid">21978948</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="patent" id="cit16"><person-group person-group-type="allauthors"><name><surname>Takemoto</surname><given-names>T.</given-names></name>; <name><surname>Arichi</surname><given-names>S.</given-names></name>; <name><surname>Arihara</surname><given-names>S.</given-names></name>; <name><surname>Nakajima</surname><given-names>T.</given-names></name>; <name><surname>Okuhira</surname><given-names>M.</given-names></name>; <name><surname>Uchida</surname><given-names>Y.</given-names></name></person-group><article-title>Gynosaponins,
Their Use and a Process for Preparing the Same</article-title>. <patent>USUS 4,339,442A</patent><year>1982</year>.</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Takemoto</surname><given-names>T.</given-names></name>; <name><surname>Arihara</surname><given-names>S.</given-names></name>; <name><surname>Nakajima</surname><given-names>T.</given-names></name>; <name><surname>Okuhira</surname><given-names>M.</given-names></name>
<article-title>Studies on the constituents
of <italic>Gynostemma pentaphyllum</italic> Makino.
1. Structures of gypenoside-I-XIV</article-title>. <source>Yakugaku
Zasshi</source>
<year>1983</year>, <volume>103</volume>, <fpage>173</fpage>&#x02013;<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1248/yakushi1947.103.2_173</pub-id>.</mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Razmovski-Naumovski</surname><given-names>V.</given-names></name>; <name><surname>Huang</surname><given-names>T. H.-W.</given-names></name>; <name><surname>Tran</surname><given-names>V. H.</given-names></name>; <name><surname>Li</surname><given-names>G. Q.</given-names></name>; <name><surname>Duke</surname><given-names>C. C.</given-names></name>; <name><surname>Roufogalis</surname><given-names>B. D.</given-names></name>
<article-title>Chemistry
and pharmacology of <italic>Gynostemma
pentaphyllum</italic></article-title>. <source>Phytochem. Rev.</source>
<year>2005</year>, <volume>4</volume>, <fpage>197</fpage>&#x02013;<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1007/s11101-005-3754-4</pub-id>.</mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Chen</surname><given-names>J.</given-names></name>
<article-title>Antistress
action of <italic>Gynostemma pentaphyllum</italic></article-title>. <source>Chin. Tradit. Pat. Med.</source>
<year>1989</year>, <volume>11</volume>, <fpage>31</fpage>&#x02013;<lpage>32</lpage>.</mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Jin</surname><given-names>M.</given-names></name>
<article-title>Effects of
extract of <italic>Gynostemma pentaphyllum</italic> on
human rectal adenocarcinoma cell</article-title>. <source>Mod. Appl.
Pharm.</source>
<year>1992</year>, <volume>9</volume>, <fpage>49</fpage>&#x02013;<lpage>52</lpage>.</mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Wu</surname><given-names>J.</given-names></name>; <name><surname>Chen</surname><given-names>Z.</given-names></name>; <name><surname>Zhang</surname><given-names>C.</given-names></name>; <name><surname>Lu</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>
<article-title>Effective
and preparative separation of bioactive flavonoids from <italic>Gynostemma pentaphyllum</italic> tea using elution-extrusion
counter-current chromatography</article-title>. <source>Sep. Sci. Technol.</source>
<year>2013</year>, <volume>48</volume>, <fpage>909</fpage>&#x02013;<lpage>914</lpage>. <pub-id pub-id-type="doi">10.1080/01496395.2012.710887</pub-id>.</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Zhao</surname><given-names>Y.</given-names></name>; <name><surname>Xie</surname><given-names>Z.</given-names></name>; <name><surname>Niu</surname><given-names>Y.</given-names></name>; <name><surname>Shi</surname><given-names>H.</given-names></name>; <name><surname>Chen</surname><given-names>P.</given-names></name>; <name><surname>Yu</surname><given-names>L. L.</given-names></name>
<article-title>Chemical
compositions, HPLC/MS fingerprinting profiles and radical scavenging
properties of commercial <italic>Gynostemma pentaphyllum</italic> (Thunb.) Makino samples</article-title>. <source>Food Chem.</source>
<year>2012</year>, <volume>134</volume>, <fpage>180</fpage>&#x02013;<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2012.02.090</pub-id>.</mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Circosta</surname><given-names>C.</given-names></name>; <name><surname>De Pasquale</surname><given-names>R.</given-names></name>; <name><surname>Occhiuto</surname><given-names>F.</given-names></name>
<article-title>Cardiovascular effects of the aqueous
extract of <italic>Gynostemma pentaphyllum</italic> Makino</article-title>. <source>Phytomedicine</source>
<year>2005</year>, <volume>12</volume> (<issue>9</issue>), <fpage>638</fpage>&#x02013;<lpage>643</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2004.06.023</pub-id>.<pub-id pub-id-type="pmid">16194050</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Jang</surname><given-names>Y.-J.</given-names></name>; <name><surname>Kim</surname><given-names>J.-K.</given-names></name>; <name><surname>Lee</surname><given-names>M.-S.</given-names></name>; <name><surname>Ham</surname><given-names>I.-H.</given-names></name>; <name><surname>Whang</surname><given-names>W.-K.</given-names></name>; <name><surname>Kim</surname><given-names>K.-H.</given-names></name>; <name><surname>Kim</surname><given-names>H.-J.</given-names></name>
<article-title>Hypoglycemic
and hypolipidemic effects
of crude saponin fractions from <italic>Panax ginseng</italic> and <italic>Gynostemma pentaphyllum</italic></article-title>. <source>Pharmaceutical
Society of Korea</source>
<year>2001</year>, <volume>45</volume> (<issue>5</issue>), <fpage>545</fpage>&#x02013;<lpage>556</lpage>.</mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Wang</surname><given-names>Y.</given-names></name>
<article-title>Antitumor
effect of gypenoside</article-title>. <source>Chin. J. Modern Develop.Trad.
Med.</source>
<year>1988</year>, <volume>8</volume> (<issue>5</issue>), <fpage>286</fpage>.</mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Zhou</surname><given-names>Z.</given-names></name>; <name><surname>Zhang</surname><given-names>S.</given-names></name>; <name><surname>Li</surname><given-names>W.</given-names></name>; <name><surname>Jin</surname><given-names>Z.</given-names></name>
<article-title>Observation of the
effectiveness of compound <italic>Gynostemma pentaphyllum</italic> Mak in golden hamster cheek pouch's premalignancy</article-title>. <source>Shanghai J. Stomatolog.</source>
<year>1996</year>, <volume>5</volume> (<issue>2</issue>), <fpage>74</fpage>&#x02013;<lpage>76</lpage>.</mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Han</surname><given-names>M.</given-names></name>; <name><surname>Liu</surname><given-names>J.</given-names></name>; <name><surname>Gao</surname><given-names>H.</given-names></name>
<article-title>Effects of 24 Chinese medicinal herbs on nucleic acid,
protein and cell cycle of human lung adenocarcinoma cell</article-title>. <source>Chin. J. Integr. Trad. West. Med.</source>
<year>1995</year>, <volume>15</volume> (<issue>3</issue>), <fpage>147</fpage>&#x02013;<lpage>149</lpage>.</mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Takagi</surname><given-names>J.</given-names></name>; <name><surname>Imada</surname><given-names>T.</given-names></name>; <name><surname>Kikuchi</surname><given-names>T.</given-names></name>; <name><surname>Saito</surname><given-names>Y.</given-names></name>; <name><surname>Inada</surname><given-names>Y.</given-names></name>
<article-title>A new platelet aggregation factor from <italic>Gynostemma pentaphyllum</italic> Makino</article-title>. <source>Chem.
Pharm. Bull.</source>
<year>1985</year>, <volume>33</volume> (<issue>12</issue>), <fpage>5568</fpage>&#x02013;<lpage>5571</lpage>. <pub-id pub-id-type="doi">10.1248/cpb.33.5568</pub-id>.<pub-id pub-id-type="pmid">3833397</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Tsai</surname><given-names>T.-H.</given-names></name>; <name><surname>Tsai</surname><given-names>T.-H.</given-names></name>; <name><surname>Chien</surname><given-names>Y.-C.</given-names></name>; <name><surname>Lee</surname><given-names>C.-W.</given-names></name>; <name><surname>Tsai</surname><given-names>P.-J.</given-names></name>
<article-title>In vitro
antimicrobial activities against cariogenic streptococci and their
antioxidant capacities: A comparative study of green tea versus different
herbs</article-title>. <source>Food Chem.</source>
<year>2008</year>, <volume>110</volume> (<issue>4</issue>), <fpage>859</fpage>&#x02013;<lpage>864</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2008.02.085</pub-id>.<pub-id pub-id-type="pmid">26047271</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Zhang</surname><given-names>Q.-B.</given-names></name>; <name><surname>Ma</surname><given-names>J.-J.</given-names></name>; <name><surname>Chao</surname><given-names>Z.-X.</given-names></name>; <name><surname>Lin</surname><given-names>Z.-B.</given-names></name>
<article-title>Therapeutic rote
and its mechanism of gypenosides on delayed healing of experimental
gastric ulcer inducing by NCTC11637 strain HP in rats</article-title>. <source>Chin. Pharmacolog. Bull.</source>
<year>1999</year>, <volume>15</volume>, <fpage>225</fpage>&#x02013;<lpage>228</lpage>.</mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Gauhar</surname><given-names>R.</given-names></name>; <name><surname>Hwang</surname><given-names>S.-L.</given-names></name>; <name><surname>Jeong</surname><given-names>S.-S.</given-names></name>; <name><surname>Kim</surname><given-names>J.-E.</given-names></name>; <name><surname>Song</surname><given-names>H.</given-names></name>; <name><surname>Park</surname><given-names>D. C.</given-names></name>; <name><surname>Song</surname><given-names>K.-S.</given-names></name>; <name><surname>Kim</surname><given-names>T. Y.</given-names></name>; <name><surname>Oh</surname><given-names>W. K.</given-names></name>; <name><surname>Huh</surname><given-names>T.-L.</given-names></name>
<article-title>Heat-processed <italic>Gynostemma pentaphyllum</italic> extract improves obesity in ob/ob mice by activating AMP-activated
protein kinase</article-title>. <source>Biotechnol. Lett.</source>
<year>2012</year>, <volume>34</volume> (<issue>9</issue>), <fpage>1607</fpage>&#x02013;<lpage>1616</lpage>. <pub-id pub-id-type="doi">10.1007/s10529-012-0944-1</pub-id>.<pub-id pub-id-type="pmid">22576281</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Matthias</surname><given-names>A.</given-names></name>; <name><surname>Blanchfield</surname><given-names>J.</given-names></name>; <name><surname>Penman</surname><given-names>K.</given-names></name>; <name><surname>Bone</surname><given-names>K.</given-names></name>; <name><surname>Toth</surname><given-names>I.</given-names></name>; <name><surname>Lehmann</surname><given-names>R.</given-names></name>
<article-title>Permeability studies of Kavalactones using a Caco-2
cell monolayer model</article-title>. <source>J. Clin. Pharm. Ther.</source>
<year>2007</year>, <volume>32</volume>, <fpage>233</fpage>&#x02013;<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2710.2007.00810.x</pub-id>.<pub-id pub-id-type="pmid">17489874</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Volpe</surname><given-names>D. A.</given-names></name>
<article-title>Variability
in Caco-2 and MDCK cell-based intestinal permeability assays</article-title>. <source>J. Pharm. Sci.</source>
<year>2008</year>, <volume>97</volume>, <fpage>712</fpage>&#x02013;<lpage>725</lpage>. <pub-id pub-id-type="doi">10.1002/jps.21010</pub-id>.<pub-id pub-id-type="pmid">17542022</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Press</surname><given-names>B.</given-names></name>; <name><surname>Di Grandi</surname><given-names>D.</given-names></name>
<article-title>Permeability
for intestinal absorption: Caco-2 assay
and related issues</article-title>. <source>Curr. Drug Metab.</source>
<year>2008</year>, <volume>9</volume>, <fpage>893</fpage>&#x02013;<lpage>900</lpage>. <pub-id pub-id-type="doi">10.2174/138920008786485119</pub-id>.<pub-id pub-id-type="pmid">18991586</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Barrington</surname><given-names>R.</given-names></name>; <name><surname>Williamson</surname><given-names>G.</given-names></name>; <name><surname>Bennett</surname><given-names>R. N.</given-names></name>; <name><surname>Davis</surname><given-names>B. D.</given-names></name>; <name><surname>Brodbelt</surname><given-names>J. S.</given-names></name>; <name><surname>Kroon</surname><given-names>P. A.</given-names></name>
<article-title>Absorption,
conjugation and efflux of the flavonoids,
kaempferol and galangin, using the intestinal CaCo-2/TC7 cell model</article-title>. <source>J. Funct. Foods</source>
<year>2009</year>, <volume>1</volume>, <fpage>74</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.jff.2008.09.011</pub-id>.<pub-id pub-id-type="pmid">20046888</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Murota</surname><given-names>K.</given-names></name>; <name><surname>Terao</surname><given-names>J.</given-names></name>
<article-title>Antioxidative flavonoid
quercetin: implication of its intestinal
absorption and metabolism</article-title>. <source>Arch. Biochem. Biophys.</source>
<year>2003</year>, <volume>417</volume>, <fpage>12</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/S0003-9861(03)00284-4</pub-id>.<pub-id pub-id-type="pmid">12921774</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Hu</surname><given-names>J.</given-names></name>; <name><surname>Reddy</surname><given-names>M. B.</given-names></name>; <name><surname>Hendrich</surname><given-names>S.</given-names></name>; <name><surname>Murphy</surname><given-names>P. A.</given-names></name>
<article-title>Soyasaponin I and
sapongenol B have limited absorption by Caco-2 intestinal cells and
limited bioavailability in women</article-title>. <source>J. Nutr.</source>
<year>2004</year>, <volume>134</volume>, <fpage>1867</fpage>&#x02013;<lpage>1873</lpage>. <pub-id pub-id-type="doi">10.1093/jn/134.8.1867</pub-id>.<pub-id pub-id-type="pmid">15284368</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Paek</surname><given-names>I. B.</given-names></name>; <name><surname>Moon</surname><given-names>Y.</given-names></name>; <name><surname>Kim</surname><given-names>J.</given-names></name>; <name><surname>Ji</surname><given-names>H. Y.</given-names></name>; <name><surname>Kim</surname><given-names>S. A.</given-names></name>; <name><surname>Sohn</surname><given-names>D. H.</given-names></name>; <name><surname>Kim</surname><given-names>J. B.</given-names></name>; <name><surname>Lee</surname><given-names>H. S.</given-names></name>
<article-title>Pharmacokinetics
of a ginseng saponin metabolite compound K in rats</article-title>. <source>Biopharm. Drug Dispos.</source>
<year>2006</year>, <volume>27</volume>, <fpage>39</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1002/bdd.481</pub-id>.<pub-id pub-id-type="pmid">16302287</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Yang</surname><given-names>Z.</given-names></name>; <name><surname>Wang</surname><given-names>J.-R.</given-names></name>; <name><surname>Niu</surname><given-names>T.</given-names></name>; <name><surname>Gao</surname><given-names>S.</given-names></name>; <name><surname>Yin</surname><given-names>T.</given-names></name>; <name><surname>You</surname><given-names>M.</given-names></name>; <name><surname>Jiang</surname><given-names>Z.-H.</given-names></name>; <name><surname>Hu</surname><given-names>M.</given-names></name>
<article-title>Inhibition
of P-glycoprotein leads
to improved oral bioavailability of compound K, an anticancer metabolite
of red ginseng extract produced by gut microflora</article-title>. <source>Drug Metab. Dispos.</source>
<year>2012</year>, <volume>40</volume>, <fpage>1538</fpage>&#x02013;<lpage>1544</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.111.044008</pub-id>.<pub-id pub-id-type="pmid">22584255</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Yang</surname><given-names>J.</given-names></name>; <name><surname>Du</surname><given-names>F.</given-names></name>; <name><surname>Gao</surname><given-names>X.</given-names></name>; <name><surname>Ma</surname><given-names>X.</given-names></name>; <name><surname>Huang</surname><given-names>Y.</given-names></name>; <name><surname>Xu</surname><given-names>F.</given-names></name>; <name><surname>Niu</surname><given-names>W.</given-names></name>; <name><surname>Wang</surname><given-names>F.</given-names></name>; <name><surname>Mao</surname><given-names>Y.</given-names></name>; et al. <article-title>Absorption and disposition
of ginsenosides after oral
administration of <italic>Panax notoginseng</italic> extract to rats</article-title>. <source>Drug Metab. Dispos.</source>
<year>2009</year>, <volume>37</volume>, <fpage>2290</fpage>&#x02013;<lpage>2298</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.109.029819</pub-id>.<pub-id pub-id-type="pmid">19786509</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Mahraoui</surname><given-names>L.</given-names></name>; <name><surname>Rodolosse</surname><given-names>A.</given-names></name>; <name><surname>Barbat</surname><given-names>A.</given-names></name>; <name><surname>Dussaulx</surname><given-names>E.</given-names></name>; <name><surname>Zweibaum</surname><given-names>A.</given-names></name>; <name><surname>Rousset</surname><given-names>M.</given-names></name>; <name><surname>Brot-Laroche</surname><given-names>E.</given-names></name>
<article-title>Presence and
differential expression
of SGLT1, GLUT1, GLUT2, GLUT3 and GLUT5 hexose-transporter mRNAs in
Caco-2 cell clones in relation to cell growth and glucose consumption</article-title>. <source>Biochem. J.</source>
<year>1994</year>, <volume>298</volume>, <fpage>629</fpage>&#x02013;<lpage>633</lpage>. <pub-id pub-id-type="doi">10.1042/bj2980629</pub-id>.<pub-id pub-id-type="pmid">8141777</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Hosoya</surname><given-names>K.-i.</given-names></name>; <name><surname>Kim</surname><given-names>K.-J.</given-names></name>; <name><surname>Lee</surname><given-names>V. H.</given-names></name>
<article-title>Age-dependent
expression of P-Glycoprotein
gp17O in Caco-2 cell monolayers</article-title>. <source>Pharm. Res.</source>
<year>1996</year>, <volume>13</volume>, <fpage>885</fpage>&#x02013;<lpage>890</lpage>. <pub-id pub-id-type="doi">10.1023/A:1016005212640</pub-id>.<pub-id pub-id-type="pmid">8792427</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>del
Hierro</surname><given-names>J. N.</given-names></name>; <name><surname>Herrera</surname><given-names>T.</given-names></name>; <name><surname>Fornari</surname><given-names>T.</given-names></name>; <name><surname>Reglero</surname><given-names>G.</given-names></name>; <name><surname>Martin</surname><given-names>D.</given-names></name>
<article-title>The gastrointestinal behavior of saponins and its significance
for their bioavailability and bioactivities</article-title>. <source>J. Funct. Foods</source>
<year>2018</year>, <volume>40</volume>, <fpage>484</fpage>&#x02013;<lpage>497</lpage>. <pub-id pub-id-type="doi">10.1016/j.jff.2017.11.032</pub-id>.</mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Sun</surname><given-names>Z.</given-names></name>; <name><surname>Wu</surname><given-names>Y.</given-names></name>; <name><surname>Yang</surname><given-names>B.</given-names></name>; <name><surname>Zhu</surname><given-names>B.</given-names></name>; <name><surname>Hu</surname><given-names>S.</given-names></name>; <name><surname>Lu</surname><given-names>Y.</given-names></name>; <name><surname>Zhao</surname><given-names>B.</given-names></name>; <name><surname>Du</surname><given-names>S.</given-names></name>
<article-title>Inhibitory
influence of <italic>Panax notoginseng</italic> saponins
on Aspirin hydrolysis
in human intestinal Caco-2 Cells</article-title>. <source>Molecules</source>
<year>2018</year>, <volume>23</volume>, <elocation-id>455</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23020455</pub-id>.</mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Li</surname><given-names>S.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Jiang</surname><given-names>T.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Yang</surname><given-names>S.</given-names></name>; <name><surname>Lv</surname><given-names>Z.</given-names></name>
<article-title>Absorption and transport
of sea cucumber saponins from <italic>Apostichopus japonicus</italic></article-title>. <source>Mar.
Drugs</source>
<year>2016</year>, <volume>14</volume>, <elocation-id>114</elocation-id><pub-id pub-id-type="doi">10.3390/md14060114</pub-id>.</mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Koda</surname><given-names>Y.</given-names></name>; <name><surname>Del Borgo</surname><given-names>M.</given-names></name>; <name><surname>Wessling</surname><given-names>S. T.</given-names></name>; <name><surname>Lazarus</surname><given-names>L. H.</given-names></name>; <name><surname>Okada</surname><given-names>Y.</given-names></name>; <name><surname>Toth</surname><given-names>I.</given-names></name>; <name><surname>Blanchfield</surname><given-names>J. T.</given-names></name>
<article-title>Synthesis and in vitro evaluation
of a library of modified endomorphin 1 peptides</article-title>. <source>Bioorg. Med. Chem.</source>
<year>2008</year>, <volume>16</volume>, <fpage>6286</fpage>&#x02013;<lpage>6296</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2008.04.020</pub-id>.<pub-id pub-id-type="pmid">18468445</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="thesis" id="cit38"><person-group person-group-type="allauthors"><name><surname>Ahmed</surname><given-names>I.</given-names></name></person-group><article-title>Phytochemistry
of <italic>Gynostemma pentaphyllum</italic> (Thunb.)
Makino</article-title>. Ph.D. Thesis, <publisher-name>The University
of Queensland</publisher-name>, <year>2019</year>.</mixed-citation></ref></ref-list></back></article>